SYNLAB Group (‘SYNLAB’ or ‘the Group’) today announces the appointment of Mathieu Floreani as Group Chief Business Officer (‘CBO’) and Deputy Chief Executive Officer (‘CEO’) with effect from September 8, 2017. The introduction of the new CBO role marks the next phase of SYNLAB’s growth and reflects the need for SYNLAB to address the challenges brought about by the Group’s sustained growth across geographic regions and the increased scope of the business. Mathieu Floreani will be reporting to the Group CEO Dr Bartl Wimmer.
In his new role, Mr. Floreani will be responsible for coordinating SYNLAB’s ongoing business and organic growth. In addition he will focus on harmonising and promoting the implementation of commercial best practices across the Group which will enable SYNLAB to further improve its services for patients and customers.
Dr Bartl Wimmer, CEO of SYNLAB Group: “I am pleased to welcome Mathieu as my Deputy and new Group CBO. He brings significant experience to the Board of SYNLAB given his previous CEO and executive positions in several leading global businesses. On behalf of the entire Board, we look forward to working with him and benefiting from his passion for driving a commercial mindset and operational excellence within our organisation to boost and improve our international growth. Mathieu will be one of the key people steering SYNLAB’s development as we enter the next phase of growth.”
Mathieu Floreani was formerly CEO of the Forwarding division of DHL in the Americas, where he led an organisation operating across 20 countries. Previously he turned around the Express business of DHL in Canada, and prior to that was Vice President Commercial at DHL Express in France. He joined DHL from McKinsey, where he was an Associate Principal and led strategy and organisational engagements, advising companies across different industries. He started his career in the Chemicals business of Total.